The global fusion protein market is expected to grow at a CAGR of 8.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for recombinant proteins in various therapeutic applications such as chimeric protein drugs and biological technology. The immunoglobulin (Ig) fusion protein segment accounted for the largest share of the global fusion protein market in 2018, followed by parathyroid hormone (PTH) fusion protein and cytokines recombinant fusion proteins segments.
Some Of The Growth Factors Of This Market:
- The global population is increasing and the demand for protein is expected to increase as well.
- The global population is aging and the demand for protein is expected to increase as well.
- There are more people in the world who are becoming vegetarian or vegan, which means they need more protein from other sources than just meat products, such as soybeans, nuts, beans, lentils and peas.
- There are more people in the world who have a higher income level which means they can afford to buy more expensive food items like meat products that contain higher levels of protein than other food items like vegetables or grains that contain lower levels of protein per serving size.
- More people in the world are living an active lifestyle which means they need a higher intake of proteins.
Industry Growth Insights published a new data on “Fusion Protein Market”. The research report is titled “Fusion Protein Market research by Types (Immunoglobulin (Ig) Fusion Protein, Parathyroid Hormone (PTH) Fusion Protein, Cytokines Recombinant Fusion Protein, Others), By Applications (Chimeric Protein Drugs, Biological Technology, Others), By Players/Companies Abnova, NOVUS, Origene, Chimerigen, Peprotech, ProSpec, Roche, Absolute Antibody, Amgen Science”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fusion Protein Market Research Report
By Type
Immunoglobulin (Ig) Fusion Protein, Parathyroid Hormone (PTH) Fusion Protein, Cytokines Recombinant Fusion Protein, Others
By Application
Chimeric Protein Drugs, Biological Technology, Others
By Companies
Abnova, NOVUS, Origene, Chimerigen, Peprotech, ProSpec, Roche, Absolute Antibody, Amgen Science
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Fusion Protein Market Report Segments:
The global Fusion Protein market is segmented on the basis of:
Types
Immunoglobulin (Ig) Fusion Protein, Parathyroid Hormone (PTH) Fusion Protein, Cytokines Recombinant Fusion Protein, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Chimeric Protein Drugs, Biological Technology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abnova
- NOVUS
- Origene
- Chimerigen
- Peprotech
- ProSpec
- Roche
- Absolute Antibody
- Amgen Science
Highlights of The Fusion Protein Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunoglobulin (Ig) Fusion Protein
- Parathyroid Hormone (PTH) Fusion Protein
- Cytokines Recombinant Fusion Protein
- Others
- By Application:
- Chimeric Protein Drugs
- Biological Technology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fusion Protein Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A fusion protein is a protein that is composed of two or more proteins. Fusion proteins are often created to improve the effectiveness of a particular treatment or to create new treatments.
Some of the major companies in the fusion protein market are Abnova, NOVUS, Origene, Chimerigen, Peprotech, ProSpec, Roche, Absolute Antibody, Amgen Science.
The fusion protein market is expected to grow at a compound annual growth rate of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Fusion Protein Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Fusion Protein Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Fusion Protein Market - Supply Chain
4.5. Global Fusion Protein Market Forecast
4.5.1. Fusion Protein Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Fusion Protein Market Size (000 Units) and Y-o-Y Growth
4.5.3. Fusion Protein Market Absolute $ Opportunity
5. Global Fusion Protein Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Fusion Protein Market Size and Volume Forecast by Type
5.3.1. Immunoglobulin (Ig) Fusion Protein
5.3.2. Parathyroid Hormone (PTH) Fusion Protein
5.3.3. Cytokines Recombinant Fusion Protein
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Fusion Protein Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Fusion Protein Market Size and Volume Forecast by Application
6.3.1. Chimeric Protein Drugs
6.3.2. Biological Technology
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Fusion Protein Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Fusion Protein Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Fusion Protein Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Fusion Protein Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Fusion Protein Demand Share Forecast, 2019-2026
9. North America Fusion Protein Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Fusion Protein Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Fusion Protein Market Size and Volume Forecast by Application
9.4.1. Chimeric Protein Drugs
9.4.2. Biological Technology
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Fusion Protein Market Size and Volume Forecast by Type
9.7.1. Immunoglobulin (Ig) Fusion Protein
9.7.2. Parathyroid Hormone (PTH) Fusion Protein
9.7.3. Cytokines Recombinant Fusion Protein
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Fusion Protein Demand Share Forecast, 2019-2026
10. Latin America Fusion Protein Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Fusion Protein Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Fusion Protein Market Size and Volume Forecast by Application
10.4.1. Chimeric Protein Drugs
10.4.2. Biological Technology
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Fusion Protein Market Size and Volume Forecast by Type
10.7.1. Immunoglobulin (Ig) Fusion Protein
10.7.2. Parathyroid Hormone (PTH) Fusion Protein
10.7.3. Cytokines Recombinant Fusion Protein
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Fusion Protein Demand Share Forecast, 2019-2026
11. Europe Fusion Protein Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Fusion Protein Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Fusion Protein Market Size and Volume Forecast by Application
11.4.1. Chimeric Protein Drugs
11.4.2. Biological Technology
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Fusion Protein Market Size and Volume Forecast by Type
11.7.1. Immunoglobulin (Ig) Fusion Protein
11.7.2. Parathyroid Hormone (PTH) Fusion Protein
11.7.3. Cytokines Recombinant Fusion Protein
11.7.4. Others
118. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Fusion Protein Demand Share, 2019-2026
12. Asia Pacific Fusion Protein Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Fusion Protein Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Fusion Protein Market Size and Volume Forecast by Application
12.4.1. Chimeric Protein Drugs
12.4.2. Biological Technology
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Fusion Protein Market Size and Volume Forecast by Type
12.7.1. Immunoglobulin (Ig) Fusion Protein
12.7.2. Parathyroid Hormone (PTH) Fusion Protein
12.7.3. Cytokines Recombinant Fusion Protein
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Fusion Protein Demand Share, 2019-2026
13. Middle East & Africa Fusion Protein Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Fusion Protein Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Fusion Protein Market Size and Volume Forecast by Application
13.4.1. Chimeric Protein Drugs
13.4.2. Biological Technology
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Fusion Protein Market Size and Volume Forecast by Type
13.7.1. Immunoglobulin (Ig) Fusion Protein
13.7.2. Parathyroid Hormone (PTH) Fusion Protein
13.7.3. Cytokines Recombinant Fusion Protein
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Fusion Protein Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Fusion Protein Market: Market Share Analysis
14.2. Fusion Protein Distributors and Customers
14.3. Fusion Protein Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abnova
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. NOVUS
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Origene
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Chimerigen
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Peprotech
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. ProSpec
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Roche
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Absolute Antibody
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Amgen Science
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
